Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT00416793 · TERMINATED

Trial details

NCT number: NCT00416793
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer

Start date: 2006-12-01
Primary completion: 2009-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.